Does DARATUMUMAB Cause Urinary tract infection? 288 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 288 reports of Urinary tract infection have been filed in association with DARATUMUMAB (DARZALEX). This represents 1.1% of all adverse event reports for DARATUMUMAB.
288
Reports of Urinary tract infection with DARATUMUMAB
1.1%
of all DARATUMUMAB reports
71
Deaths
183
Hospitalizations
How Dangerous Is Urinary tract infection From DARATUMUMAB?
Of the 288 reports, 71 (24.7%) resulted in death, 183 (63.5%) required hospitalization, and 34 (11.8%) were considered life-threatening.
Is Urinary tract infection Listed in the Official Label?
Yes, Urinary tract infection is listed as a known adverse reaction in the official FDA drug label for DARATUMUMAB.
What Other Side Effects Does DARATUMUMAB Cause?
Plasma cell myeloma (2,980)
Infusion related reaction (2,557)
Off label use (2,494)
Pneumonia (1,450)
Neutropenia (1,351)
Drug ineffective (1,110)
Thrombocytopenia (1,089)
Death (1,088)
Pyrexia (1,032)
Dyspnoea (996)
What Other Drugs Cause Urinary tract infection?
ADALIMUMAB (6,375)
LENALIDOMIDE (4,247)
ETANERCEPT (3,915)
OCRELIZUMAB (3,618)
TOFACITINIB (3,179)
METHOTREXATE (2,960)
DALFAMPRIDINE (2,757)
RITUXIMAB (2,579)
CARBIDOPA\LEVODOPA (2,151)
ABATACEPT (2,110)
Which DARATUMUMAB Alternatives Have Lower Urinary tract infection Risk?
DARATUMUMAB vs DARATUMUMAB\HYALURONIDASE-FIHJ
DARATUMUMAB vs DARBEPOETIN ALFA
DARATUMUMAB vs DARIDOREXANT
DARATUMUMAB vs DARIFENACIN HYDROBROMIDE
DARATUMUMAB vs DAROLUTAMIDE